| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33915284_HAS_TOPIC_C0021081> <https://research.tib.eu/covid-19/entity/33915284_HAS_TOPIC_C0021760> <https://research.tib.eu/covid-19/entity/33915284_HAS_TOPIC_C0028873> <https://research.tib.eu/covid-19/entity/33915284_HAS_TOPIC_C0032042> <https://research.tib.eu/covid-19/entity/33915284_HAS_TOPIC_C0035205> <https://research.tib.eu/covid-19/entity/33915284_HAS_TOPIC_C0085415> <https://research.tib.eu/covid-19/entity/33915284_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33915284_HAS_TOPIC_C0087113> <https://research.tib.eu/covid-19/entity/33915284_HAS_TOPIC_C0199470> <https://research.tib.eu/covid-19/entity/33915284_HAS_TOPIC_C0600378> <https://research.tib.eu/covid-19/entity/33915284_HAS_TOPIC_C1609165> <https://research.tib.eu/covid-19/entity/33915284_HAS_TOPIC_C2740854> <https://research.tib.eu/covid-19/entity/33915284_HAS_TOPIC_C2830231> <https://research.tib.eu/covid-19/entity/33915284_HAS_TOPIC_C2936643> <https://research.tib.eu/covid-19/entity/33915284_HAS_TOPIC_C2985546> <https://research.tib.eu/covid-19/entity/33915284_HAS_TOPIC_C3272237> <https://research.tib.eu/covid-19/entity/33915284_HAS_TOPIC_C3850123> <https://research.tib.eu/covid-19/entity/33915284_HAS_TOPIC_C4704925> <https://research.tib.eu/covid-19/entity/33915284_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33915284_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/33915284_HAS_TOPIC_C5226663> <https://research.tib.eu/covid-19/entity/33915284_HAS_TOPIC_C5227770> <https://research.tib.eu/covid-19/entity/33915284_HAS_TOPIC_C5227771> <https://research.tib.eu/covid-19/entity/33915284_HAS_TOPIC_C5227772> <https://research.tib.eu/covid-19/entity/33915284_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Infectious Diseases Section, Department of Medical Specialties King Fahad Medical City, Riyadh, Saudi Arabia; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia; Division of Infectious Diseases, Mayo Clinic College of Medicine and Science, Rochester, MN, USA; Division of Epidemiology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA. Electronic address: Tleyjeh.Imad@mayo.edu.\', \'Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.\', \'Department of Public Health, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.\', \'Mayo Clinic Libraries, Mayo Clinic, Rochester, MN, USA.\', \'BP-A Beneficência Portuguesa de São Paulo, Rua Maestro Cardim, São Paulo, Brazil; Brazilian Research in Intensive Care Network-BRICNet, São Paulo, SP, Brazil.\', \'Department of Cardiac Sciences, King Fahad Cardiac Center, King Saud University Medical City, Riyadh, Saudi Arabia.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Hassett_Leslie> <https://research.tib.eu/covid-19/entity/Kashour_Tarek> <https://research.tib.eu/covid-19/entity/Kashour_Zakariya> <https://research.tib.eu/covid-19/entity/Riaz_Muhammad> <https://research.tib.eu/covid-19/entity/Tleyjeh_Imad_M> <https://research.tib.eu/covid-19/entity/Veiga_Viviane_C>
?:doi	<https://research.tib.eu/covid-19/entity/S1198-743X%2821%2900204-410.1016/j.cmi.2021.04.019>
?:doi	S1198-743X(21)00204-410.1016/j.cmi.2021.04.019
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Meta-Analysis> <https://research.tib.eu/covid-19/entity/Systematic_Review>
?:journal	Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33915284>
?:pmid	<https://research.tib.eu/covid-19/entity/33915284>
?:pmid	33915284
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0442886_PROCESS_OF_C0870668> <https://research.tib.eu/covid-19/entity/C0598905_COEXISTS_WITH_C1850165> <https://research.tib.eu/covid-19/entity/C1609165_PREDISPOSES_C0442886>
?:title	Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis, first update.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Property

Value

is ?:annotates of

?:authorAffiliation

[\'Infectious Diseases Section, Department of Medical Specialties King Fahad Medical City, Riyadh, Saudi Arabia; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia; Division of Infectious Diseases, Mayo Clinic College of Medicine and Science, Rochester, MN, USA; Division of Epidemiology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA. Electronic address: Tleyjeh.Imad@mayo.edu.\', \'Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.\', \'Department of Public Health, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.\', \'Mayo Clinic Libraries, Mayo Clinic, Rochester, MN, USA.\', \'BP-A Beneficência Portuguesa de São Paulo, Rua Maestro Cardim, São Paulo, Brazil; Brazilian Research in Intensive Care Network-BRICNet, São Paulo, SP, Brazil.\', \'Department of Cardiac Sciences, King Fahad Cardiac Center, King Saud University Medical City, Riyadh, Saudi Arabia.\']

?:citedBy